Commonwealth Equity Services, LLC Ovid Therapeutics Inc. Transaction History

Commonwealth Equity Services, LLC

  • $66 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021
SELL
$2.28 - $6.84 $41,952 - $125,856
-18,400 Closed
0 $0
Q3 2020

Nov 05, 2020
BUY
$5.39 - $8.24 $5,390 - $8,240
1,000 Added 5.75%
18,400 $105,000
Q1 2020

May 11, 2020
SELL
$2.03 - $4.35 $1,014 - $2,175
-500 Reduced 2.79%
17,400 $51,000
Q4 2019

Feb 05, 2020
BUY
$2.08 - $5.06 $1,040 - $2,530
500 Added 2.87%
17,900 $74,000
Q3 2019

Oct 30, 2019
BUY
$1.76 - $3.51 $30,624 - $61,073
17,400 New
17,400 $56,000

Others Institutions Holding OVID

# of Institutions
75
Shares Held
39M
Call Options Held
37.4K
Put Options Held
500
View Full List

About Ovid Therapeutics Inc.

OVID Quotes by TradingView
  • Ticker OVID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,419,400
  • Market Cap $73.9M
  • Description
  • Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...
More about OVID
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email